- Home
- GLW vs BDX Comparison
GLW vs BDX Comparison
Compare GLW & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLW
- BDX
- Stock Information
- Founded
- GLW 1851
- BDX 1897
- Country
- GLW United States
- BDX United States
- Employees
- GLW N/A
- BDX N/A
- Industry
- GLW Telecommunications Equipment
- BDX Medical/Dental Instruments
- Sector
- GLW Industrials
- BDX Health Care
- Exchange
- GLW Nasdaq
- BDX Nasdaq
- Market Cap
- GLW 44.4B
- BDX 49.0B
- IPO Year
- GLW N/A
- BDX 1962
- Fundamental
- Price
- GLW $51.59
- BDX $175.90
- Analyst Decision
- GLW Buy
- BDX Buy
- Analyst Count
- GLW 12
- BDX 9
- Target Price
- GLW $55.27
- BDX $231.50
- AVG Volume (30 Days)
- GLW 3.9M
- BDX 2.7M
- Earning Date
- GLW 07-29-2025
- BDX 08-07-2025
- Dividend Yield
- GLW 2.17%
- BDX 2.36%
- EPS Growth
- GLW N/A
- BDX 14.07
- EPS
- GLW 0.52
- BDX 5.16
- Revenue
- GLW $13,595,000,000.00
- BDX $20,867,000,000.00
- Revenue This Year
- GLW $20.06
- BDX $9.26
- Revenue Next Year
- GLW $7.75
- BDX $4.87
- P/E Ratio
- GLW $99.10
- BDX $34.08
- Revenue Growth
- GLW 9.77
- BDX 5.84
- 52 Week Low
- GLW $37.18
- BDX $163.33
- 52 Week High
- GLW $55.33
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- GLW 53.58
- BDX 53.25
- Support Level
- GLW $52.31
- BDX $172.34
- Resistance Level
- GLW $53.16
- BDX $179.76
- Average True Range (ATR)
- GLW 0.77
- BDX 3.34
- MACD
- GLW -0.16
- BDX 0.84
- Stochastic Oscillator
- GLW 44.04
- BDX 68.52
About GLW Corning Incorporated
Corning is a leader in materials science, specializing in the production of glass, ceramics, and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.